| Year |
Citation |
Score |
| 2020 |
Fralick M, Kim SC, Schneeweiss S, Everett BM, Glynn RJ, Patorno E. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. Bmj (Clinical Research Ed.). 370: m2812. PMID 32843476 DOI: 10.1136/Bmj.M2812 |
0.333 |
|
| 2020 |
Ajala ON, Demler OV, Liu Y, Farukhi Z, Adelman SJ, Collins HL, Ridker PM, Rader DJ, Glynn RJ, Mora S. Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial. Journal of the American Heart Association. e016507. PMID 32799709 DOI: 10.1161/Jaha.119.016507 |
0.346 |
|
| 2020 |
Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N. Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial. European Heart Journal. PMID 32221587 DOI: 10.1093/Eurheartj/Ehaa160 |
0.31 |
|
| 2020 |
Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, et al. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Annals of Internal Medicine. PMID 32066146 DOI: 10.7326/M19-3369 |
0.312 |
|
| 2020 |
Dave C, Kim SC, Goldfine A, Glynn R, Patorno E. 35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy Diabetes. 69. DOI: 10.2337/Db20-35-Or |
0.342 |
|
| 2020 |
Dashti H, Liu Y, Glynn RJ, Ridker PM, Mora S, Demler O. Abstract P280: Revisiting CVD Risk Prediction Using Machine Learning Approaches: A Case Study Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P280 |
0.333 |
|
| 2020 |
Ajala ON, Demler O, Liu Y, Ridker P, Glynn RJ, Chasman D, Mora S. Abstract P260: Determinants of Statin Response: A Secondary Analysis of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P260 |
0.312 |
|
| 2019 |
Akinkuolie AO, Lawler PR, Chu AY, Caulfield M, Mu J, Ding B, Nyberg F, Glynn RJ, Ridker PM, Hurt-Camejo E, Chasman DI, Mora S. Group IIA Secretory Phospholipase A and Incident Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA118311894. PMID 31070471 DOI: 10.1161/Atvbaha.118.311894 |
0.344 |
|
| 2019 |
PATORNO E, PAWAR A, SCHNEEWEISS S, GLYNN RJ, KIM DH, EVERETT BM, BESSETTE LG, KIM SC. 247-OR: Real-World Effectiveness of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in Patients With and Without Cardiovascular Disease Diabetes. 68: 247-OR. DOI: 10.2337/Db19-247-Or |
0.33 |
|
| 2019 |
PATORNO E, KIM DH, PAWAR A, SCHNEEWEISS S, GLYNN RJ, MUNSHI M, BESSETTE LG, KIM SC. 156-OR: Risk-Benefit of SGLT2 Inhibitors (SGLT2i) vs. GLP-1 Receptor Agonists (GLP-1RA) in Routine Care of Older Adults Diabetes. 68: 156-OR. DOI: 10.2337/Db19-156-Or |
0.331 |
|
| 2019 |
FRALICK M, KIM SC, SCHNEEWEISS S, EVERETT BM, GLYNN RJ, PATORNO E. 1539-P: Assessing the Risk of Amputation with Canagliflozin in Middle-Aged Adults and Adults over 65 Years of Age: An Observational Study Using Three Nationwide Databases Diabetes. 68: 1539-P. DOI: 10.2337/Db19-1539-P |
0.31 |
|
| 2019 |
Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn R. COMPARATIVE PERFORMANCE OF FOUR CLAIMS-BASED FRAILTY MEASURES IN THE UNITED STATES MEDICARE DATA Innovation in Aging. 3: S684-S685. DOI: 10.1093/Geroni/Igz038.2526 |
0.318 |
|
| 2018 |
Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. American Heart Journal. 206: 80-93. PMID 30342298 DOI: 10.1016/J.Ahj.2018.09.011 |
0.339 |
|
| 2018 |
Krumme AA, Glynn RJ, Schneeweiss S, Choudhry NK, Tong AY, Gagne JJ. Defining Exposure in Observational Studies Comparing Outcomes of Treatment Discontinuation. Circulation. Cardiovascular Quality and Outcomes. 11: e004684. PMID 29991646 DOI: 10.1161/Circoutcomes.118.004684 |
0.309 |
|
| 2018 |
Burkard T, Huegle T, Layton JB, Glynn RJ, Bloechliger M, Frey N, Jick SS, Meier CR, Spoendlin J. The risk of incident osteoarthritis of the hand in statin initiators:A sequential cohort study. Arthritis Care & Research. PMID 29885074 DOI: 10.1002/Acr.23616 |
0.301 |
|
| 2018 |
PATORNO E, EVERETT BM, SCHNEEWEISS S, GLYNN RJ, LIU J, KIM SC. Comparative Cardiovascular Effectiveness of SGLT2 Inhibitors vs. Liraglutide in Routine Care Diabetes. 67: 1492-P. DOI: 10.2337/Db18-1492-P |
0.317 |
|
| 2018 |
Solomon D, Glynn RJ, MacFadyen JG, Libby P, Thuren T, Everett BM, Ridker PM. OP0014 Serum urate, gout, and cardiovascular disease in a randomised controlled trial of canakinumab: a cantos secondary analysis Annals of the Rheumatic Diseases. 77: 56-57. DOI: 10.1136/Annrheumdis-2018-Eular.1567 |
0.35 |
|
| 2018 |
Patorno E, Glynn RJ, Levin R, Huybrechts KF. BENZODIAZEPINES AND THE RISK OF ALL-CAUSE MORTALITY IN OLDER PATIENTS Innovation in Aging. 2: 852-853. DOI: 10.1093/Geroni/Igy023.3178 |
0.302 |
|
| 2018 |
Durazo EM, Cabeza de Baca T, Slopen N, Parikh NI, Buring JE, Glynn RJ, Albert MA. Parity, Job Strain, and Cardiovascular Risk in the Women’s Health Study Current Cardiovascular Risk Reports. 12. DOI: 10.1007/S12170-018-0571-Z |
0.305 |
|
| 2017 |
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, ... ... Glynn RJ, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England Journal of Medicine. PMID 28845751 DOI: 10.1056/Nejmoa1707914 |
0.306 |
|
| 2017 |
Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF. Benzodiazepines and risk of all cause mortality in adults: cohort study. Bmj (Clinical Research Ed.). 358: j2941. PMID 28684397 DOI: 10.1136/Bmj.J2941 |
0.368 |
|
| 2017 |
Khera AV, Demler O, Adelman SJ, Collins HL, Glynn RJ, Ridker PM, Rader DJ, Mora S. Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events. An Analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Circulation. PMID 28450350 DOI: 10.1161/Circulationaha.116.025678 |
0.316 |
|
| 2017 |
Rautiainen S, Gaziano JM, Christen WG, Bubes V, Kotler G, Glynn RJ, Manson JE, Buring JE, Sesso HD. Effect of Baseline Nutritional Status on Long-term Multivitamin Use and Cardiovascular Disease Risk: A Secondary Analysis of the Physicians' Health Study II Randomized Clinical Trial. Jama Cardiology. PMID 28384735 DOI: 10.1001/Jamacardio.2017.0176 |
0.322 |
|
| 2017 |
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJ, Koenig W, Lorenzatti A, Manga P, et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine. PMID 28304242 DOI: 10.1056/Nejmoa1701488 |
0.353 |
|
| 2016 |
Ridker PM, Amarenco P, Brunell R, Glynn RJ, Jukema JW, Kastelein JJ, Koenig W, Nissen S, Revkin J, Santos RD, Schwartz PF, Yunis C, Tardif JC. Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials. American Heart Journal. 178: 135-44. PMID 27502861 DOI: 10.1016/J.Ahj.2016.05.010 |
0.313 |
|
| 2016 |
Desai RJ, Glynn RJ, Wang S, Gagne JJ. Performance of Disease Risk Score Matching in Nested Case-Control Studies: A Simulation Study. American Journal of Epidemiology. 183: 949-57. PMID 27189330 DOI: 10.1093/Aje/Kwv269 |
0.319 |
|
| 2016 |
Rautiainen S, Rist PM, Glynn RJ, Buring JE, Gaziano JM, Sesso HD. Multivitamin Use and the Risk of Cardiovascular Disease in Men. The Journal of Nutrition. PMID 27121531 DOI: 10.3945/Jn.115.227884 |
0.314 |
|
| 2016 |
Kumamaru H, Schneeweiss S, Glynn RJ, Setoguchi S, Gagne JJ. Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical data. Emerging Themes in Epidemiology. 13: 5. PMID 27053942 DOI: 10.1186/S12982-016-0047-X |
0.321 |
|
| 2016 |
Lawler PR, Akinkuolie AO, Chandler PD, Moorthy MV, Vandenburgh MJ, Schaumberg DA, Lee IM, Glynn RJ, Ridker PM, Buring JE, Mora S. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk. Circulation Research. 118: 1106-15. PMID 26951635 DOI: 10.1161/Circresaha.115.308078 |
0.336 |
|
| 2016 |
Kumamaru H, Gagne JJ, Glynn RJ, Setoguchi S, Schneeweiss S. Comparison of high dimensional confounder summary scores in comparative studies of newly marketed medications. Journal of Clinical Epidemiology. PMID 26931292 DOI: 10.1016/J.Jclinepi.2016.02.011 |
0.33 |
|
| 2016 |
Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women. Ophthalmic Epidemiology. 1-8. PMID 26786311 DOI: 10.3109/09286586.2015.1130845 |
0.304 |
|
| 2016 |
Lawler PR, Akinkuolie AO, Harada P, Glynn R, Ridker P, Mora S. RESIDUAL RISK AND ON-STATIN REDUCTIONS IN TRIGLYCERIDES, REMNANT CHOLESTEROL, AND VLDL LIPOPROTEINS: AN ANALYSIS FROM THE JUPITER TRIAL Journal of the American College of Cardiology. 67: 1853. DOI: 10.1016/S0735-1097(16)31854-X |
0.322 |
|
| 2016 |
Wyss R, Glynn RJ, Gagne JJ. A Review of Disease Risk Scores and Their Application in Pharmacoepidemiology Current Epidemiology Reports. 3: 277-284. DOI: 10.1007/S40471-016-0088-2 |
0.314 |
|
| 2015 |
Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, Glynn RJ, Ridker PM, Krauss RM. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The JUPITER Trial. Circulation. PMID 26408274 DOI: 10.1161/Circulationaha.115.016857 |
0.302 |
|
| 2015 |
Jiménez MC, Rexrode KM, Glynn RJ, Ridker PM, Gaziano JM, Sesso HD. Association Between High-Sensitivity C-Reactive Protein and Total Stroke by Hypertensive Status Among Men. Journal of the American Heart Association. 4: e002073. PMID 26391131 DOI: 10.1161/Jaha.115.002073 |
0.321 |
|
| 2015 |
Chiuve SE, Sandhu RK, Moorthy MV, Glynn RJ, Albert CM. Dietary Fat Intake Is Differentially Associated with Risk of Paroxysmal Compared with Sustained Atrial Fibrillation in Women. The Journal of Nutrition. 145: 2092-101. PMID 26180251 DOI: 10.3945/Jn.115.212860 |
0.305 |
|
| 2015 |
Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 131: 1851-60. PMID 25825410 DOI: 10.1161/Circulationaha.114.014522 |
0.331 |
|
| 2015 |
Kim SC, Schneeweiss S, Choudhry N, Liu J, Glynn RJ, Solomon DH. Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study. The American Journal of Medicine. 128: 653.e7-653.e16. PMID 25660249 DOI: 10.1016/J.Amjmed.2015.01.013 |
0.323 |
|
| 2015 |
Franklin JM, Schneeweiss S, Huybrechts KF, Glynn RJ. Evaluating possible confounding by prescriber in comparative effectiveness research. Epidemiology (Cambridge, Mass.). 26: 238-41. PMID 25643103 DOI: 10.1097/Ede.0000000000000241 |
0.302 |
|
| 2015 |
Kim SC, Solomon DH, Liu J, Franklin JM, Glynn RJ, Schneeweiss S. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. The American Journal of Medicine. 128: 539.e7-17. PMID 25534420 DOI: 10.1016/J.Amjmed.2014.11.025 |
0.332 |
|
| 2015 |
Peña JM, Aspberg S, MacFadyen J, Glynn RJ, Solomon DH, Ridker PM. Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial. Jama Internal Medicine. 175: 171-7. PMID 25437881 DOI: 10.1001/Jamainternmed.2014.6388 |
0.324 |
|
| 2015 |
Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM, Blanke CD, Klein EA. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. Jama Ophthalmology. 133: 17-24. PMID 25232809 DOI: 10.1001/Jamaophthalmol.2014.3478 |
0.31 |
|
| 2015 |
Lawler PR, Akinkuolie A, Glynn R, Ridker P, Mora S. ATHEROGENIC LIPOPROTEIN PARTICLE SUBCLASSES AND RESIDUAL CARDIOVASCULAR RISK: AN ANALYSIS OF THE JUPITER TRIAL Journal of the American College of Cardiology. 65: A1362. DOI: 10.1016/S0735-1097(15)61362-6 |
0.308 |
|
| 2014 |
Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB. Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetologica. 51: 1015-23. PMID 25311055 DOI: 10.1007/S00592-014-0663-2 |
0.338 |
|
| 2014 |
Sandhu RK, Conen D, Tedrow UB, Fitzgerald KC, Pradhan AD, Ridker PM, Glynn RJ, Albert CM. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. Journal of the American Heart Association. 3: e000916. PMID 24786144 DOI: 10.1161/Jaha.114.000916 |
0.307 |
|
| 2014 |
Patorno E, Glynn RJ, Hernández-Díaz S, Liu J, Schneeweiss S. Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments. Epidemiology (Cambridge, Mass.). 25: 268-78. PMID 24487209 DOI: 10.1097/Ede.0000000000000069 |
0.327 |
|
| 2014 |
Christen WG, Glynn RJ, Manson JE, MacFadyen J, Bubes V, Schvartz M, Buring JE, Sesso HD, Gaziano JM. Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 121: 525-34. PMID 24268861 DOI: 10.1016/J.Ophtha.2013.09.038 |
0.323 |
|
| 2013 |
Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. Journal of the American Heart Association. 2: e000208. PMID 23900213 DOI: 10.1161/Jaha.113.000208 |
0.331 |
|
| 2013 |
Matsumoto C, Hanson NQ, Tsai MY, Glynn RJ, Gaziano JM, Djoussé L. Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study. Clinical Nutrition (Edinburgh, Scotland). 32: 819-23. PMID 23473794 DOI: 10.1016/J.Clnu.2013.02.006 |
0.319 |
|
| 2013 |
Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations. Epidemiology (Cambridge, Mass.). 24: 375-8. PMID 23466528 DOI: 10.1097/Ede.0B013E31828Ac9Cb |
0.304 |
|
| 2013 |
Winter AC, Berger K, Glynn RJ, Buring JE, Gaziano JM, Schürks M, Kurth T. Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. The American Journal of Medicine. 126: 228-35, 235.e1-2. PMID 23410563 DOI: 10.1016/J.Amjmed.2012.06.039 |
0.322 |
|
| 2013 |
Mitta VP, Christen WG, Glynn RJ, Semba RD, Ridker PM, Rimm EB, Hankinson SE, Schaumberg DA. C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts. Jama Ophthalmology. 131: 507-13. PMID 23392454 DOI: 10.1001/Jamaophthalmol.2013.2303 |
0.361 |
|
| 2013 |
Petrone AB, Weir N, Hanson NQ, Glynn R, Tsai MY, Gaziano JM, Djoussé L. Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study. The American Journal of Clinical Nutrition. 97: 66-71. PMID 23193008 DOI: 10.3945/Ajcn.112.048991 |
0.313 |
|
| 2012 |
Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. Jama. 308: 1871-80. PMID 23162860 DOI: 10.1001/Jama.2012.14641 |
0.314 |
|
| 2012 |
Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, Gaziano JM. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Jama. 308: 1751-60. PMID 23117775 DOI: 10.1001/Jama.2012.14805 |
0.362 |
|
| 2012 |
Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (London, England). 380: 565-71. PMID 22883507 DOI: 10.1016/S0140-6736(12)61190-8 |
0.324 |
|
| 2012 |
Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Christopher Roebuck M, Schneeweiss S. Association between the Part D coverage gap and adverse health outcomes. Journal of the American Geriatrics Society. 60: 1408-17. PMID 22788544 DOI: 10.1111/J.1532-5415.2012.04073.X |
0.339 |
|
| 2012 |
Gagne JJ, Glynn RJ, Rassen JA, Walker AM, Daniel GW, Sridhar G, Schneeweiss S. Active safety monitoring of newly marketed medications in a distributed data network: Application of a semi-automated monitoring system Clinical Pharmacology and Therapeutics. 92: 80-86. PMID 22588606 DOI: 10.1038/Clpt.2011.369 |
0.303 |
|
| 2012 |
Glynn RJ, Gagne JJ, Schneeweiss S. Role of disease risk scores in comparative effectiveness research with emerging therapies. Pharmacoepidemiology and Drug Safety. 21: 138-47. PMID 22552989 DOI: 10.1002/Pds.3231 |
0.353 |
|
| 2012 |
Polinski JM, Schneeweiss S, Glynn RJ, Lii J, Rassen JA. Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment. Pharmacoepidemiology and Drug Safety. 21: 90-8. PMID 22552984 DOI: 10.1002/Pds.3250 |
0.326 |
|
| 2012 |
Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S. Beneficiaries with cardiovascular disease and thePart D coverage gap. Circulation. Cardiovascular Quality and Outcomes. 5: 387-95. PMID 22511746 DOI: 10.1161/Circoutcomes.111.964866 |
0.315 |
|
| 2012 |
Christen WG, Glynn RJ, Sesso HD, Kurth T, Macfadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM. Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 119: 1642-9. PMID 22503302 DOI: 10.1016/J.Ophtha.2012.01.053 |
0.31 |
|
| 2012 |
Glynn RJ. Complex relations of genetic polymorphisms with nutritionally influenced biomarkers. The American Journal of Clinical Nutrition. 95: 1001-2. PMID 22492377 DOI: 10.3945/Ajcn.112.037655 |
0.355 |
|
| 2012 |
Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, Kurth T. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. Bmj Open. 2: e000866. PMID 22447047 DOI: 10.1136/Bmjopen-2012-000866 |
0.361 |
|
| 2012 |
Novack V, MacFadyen J, Malhotra A, Almog Y, Glynn RJ, Ridker PM. The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 184: E367-72. PMID 22431901 DOI: 10.1503/Cmaj.111017 |
0.342 |
|
| 2012 |
Peña JM, MacFadyen J, Glynn RJ, Ridker PM. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. European Heart Journal. 33: 531-7. PMID 22187510 DOI: 10.1093/Eurheartj/Ehr460 |
0.338 |
|
| 2012 |
Fitzgerald KC, Chiuve SE, Buring JE, Ridker PM, Glynn RJ. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. Journal of Thrombosis and Haemostasis : Jth. 10: 189-98. PMID 22151600 DOI: 10.1111/J.1538-7836.2011.04588.X |
0.317 |
|
| 2011 |
Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. American Heart Journal. 162: 106-14.e2. PMID 21742096 DOI: 10.1016/J.Ahj.2011.03.032 |
0.344 |
|
| 2011 |
Powell TM, Glynn RJ, Buring JE, Creager MA, Ridker PM, Pradhan AD. The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in women. Vascular Medicine (London, England). 16: 239-46. PMID 21730007 DOI: 10.1177/1358863X11413166 |
0.32 |
|
| 2011 |
Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, Cadarette SM, Mogun H, Brookhart MA. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 513-20. PMID 21669377 DOI: 10.1016/J.Jval.2010.10.033 |
0.338 |
|
| 2011 |
Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. Jama. 305: 2080-7. PMID 21610240 DOI: 10.1001/Jama.2011.659 |
0.337 |
|
| 2011 |
Schmidt M, Christiansen CF, Horváth-Puhó E, Glynn RJ, Rothman KJ, Sørensen HT. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism Journal of Thrombosis and Haemostasis. 9: 1326-1333. PMID 21592304 DOI: 10.1111/J.1538-7836.2011.04354.X |
0.327 |
|
| 2011 |
Ridker PM, MacFadyen JG, Glynn RJ, Chasman DI. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention. Circulation. Cardiovascular Genetics. 4: 312-7. PMID 21493817 DOI: 10.1161/Circgenetics.110.959353 |
0.335 |
|
| 2011 |
Christen WG, Schaumberg DA, Glynn RJ, Buring JE. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women. Archives of Ophthalmology (Chicago, Ill. : 1960). 129: 921-9. PMID 21402976 DOI: 10.1001/Archophthalmol.2011.34 |
0.311 |
|
| 2011 |
Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. Journal of Clinical Epidemiology. 64: 749-59. PMID 21208778 DOI: 10.1016/J.Jclinepi.2010.10.004 |
0.3 |
|
| 2011 |
Baer HJ, Glynn RJ, Hu FB, Hankinson SE, Willett WC, Colditz GA, Stampfer M, Rosner B. Risk factors for mortality in the nurses' health study: a competing risks analysis. American Journal of Epidemiology. 173: 319-29. PMID 21135028 DOI: 10.1093/Aje/Kwq368 |
0.342 |
|
| 2011 |
Terry PD, Glynn RJ, Buring JE, Sesso HD. Hypertension and risk of death from external causes in the Physicians' Health Study enrollment cohort International Journal of Public Health. 56: 231-235. DOI: 10.1007/S00038-010-0183-Y |
0.318 |
|
| 2010 |
Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Archives of Internal Medicine. 170: 1968-76. PMID 21149752 DOI: 10.1001/Archinternmed.2010.391 |
0.315 |
|
| 2010 |
Flint AJ, Rexrode KM, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, Rimm EB. Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obesity Research & Clinical Practice. 4: e171-e181. PMID 21116472 DOI: 10.1016/J.Orcp.2010.01.001 |
0.32 |
|
| 2010 |
Ridker PM, Macfadyen JG, Nordestgaard BG, Koenig W, Kastelein JJ, Genest J, Glynn RJ. Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk". Circulation. Cardiovascular Quality and Outcomes. 3: 447-52. PMID 20736443 DOI: 10.1161/Circoutcomes.110.938118 |
0.36 |
|
| 2010 |
Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, Mora S, MacFadyen JG, Glynn RJ, Kastelein JJ. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (London, England). 376: 333-9. PMID 20655105 DOI: 10.1016/S0140-6736(10)60713-1 |
0.332 |
|
| 2010 |
Ridker PM, MacFadyen J, Libby P, Glynn RJ. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). The American Journal of Cardiology. 106: 204-9. PMID 20599004 DOI: 10.1016/J.Amjcard.2010.03.018 |
0.357 |
|
| 2010 |
Ridker PM, Glynn RJ. JUPITER, rosuvastatin, and the European Medicines Agency. Lancet (London, England). 375: 2071. PMID 20494436 DOI: 10.1016/S0140-6736(10)60760-X |
0.364 |
|
| 2010 |
Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Annals of Internal Medicine. 152: 488-96, W174. PMID 20404379 DOI: 10.7326/0003-4819-152-8-201004200-00005 |
0.313 |
|
| 2010 |
Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 121: 1069-77. PMID 20176986 DOI: 10.1161/Circulationaha.109.906479 |
0.342 |
|
| 2010 |
Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and Age-Related Macular Degeneration in a Randomized Trial of Women Ophthalmology. 117: 1163-1168. PMID 20153900 DOI: 10.1016/J.Ophtha.2009.10.043 |
0.324 |
|
| 2010 |
Glynn RJ. Promises and limitations of mendelian randomization for evaluation of biomarkers. Clinical Chemistry. 56: 388-90. PMID 20093553 DOI: 10.1373/Clinchem.2009.142513 |
0.315 |
|
| 2010 |
Rassen JA, Mittleman MA, Glynn RJ, Brookhart MA, Schneeweiss S. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention European Heart Journal. 31: 561-572. PMID 19942600 DOI: 10.1093/Eurheartj/Ehp437 |
0.324 |
|
| 2010 |
Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older individuals with high C-reactive protein and low LDL levels: exploratory analysis of a randomized trial Annals of Internal Medicine. 152: 488. DOI: 10.1059/0003-4819-152-8-201004200-00005 |
0.327 |
|
| 2009 |
Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circulation. Cardiovascular Quality and Outcomes. 2: 616-23. PMID 20031900 DOI: 10.1161/Circoutcomes.109.848473 |
0.328 |
|
| 2009 |
Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, Rimm EB. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring, Md.). 18: 377-83. PMID 19629058 DOI: 10.1038/Oby.2009.223 |
0.323 |
|
| 2009 |
Glynn RJ, Rosner B, Christen WG. Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiology. 16: 98-106. PMID 19353398 DOI: 10.1080/09286580902737532 |
0.332 |
|
| 2009 |
Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation. 119: 2051-7. PMID 19349320 DOI: 10.1161/Circulationaha.108.824151 |
0.301 |
|
| 2009 |
Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. The New England Journal of Medicine. 360: 1851-61. PMID 19329822 DOI: 10.1056/Nejmoa0900241 |
0.333 |
|
| 2009 |
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (London, England). 373: 1175-82. PMID 19329177 DOI: 10.1016/S0140-6736(09)60447-5 |
0.318 |
|
| 2009 |
Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Archives of Internal Medicine. 169: 335-41. PMID 19237716 DOI: 10.1001/Archinternmed.2008.574 |
0.311 |
|
| 2009 |
Lunt M, Solomon D, Rothman K, Glynn R, Hyrich K, Symmons DP, Stürmer T. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. American Journal of Epidemiology. 169: 909-17. PMID 19153216 DOI: 10.1093/Aje/Kwn391 |
0.303 |
|
| 2009 |
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin Trial Obstetrical & Gynecological Survey. 64: 596-597. DOI: 10.1097/01.Ogx.0000358018.78512.A1 |
0.324 |
|
| 2008 |
Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, Brookhart MA. Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. American Journal of Epidemiology. 169: 273-84. PMID 19033525 DOI: 10.1093/Aje/Kwn299 |
0.311 |
|
| 2008 |
Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the Prevention of Cardiovascular Disease in Men : The Physicians' Health Study II Randomized Controlled Trial Jama. 300: 2123-2133. PMID 18997197 DOI: 10.1001/Jama.2008.600 |
0.333 |
|
| 2008 |
Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA. Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial Diabetes Care. 31: 2338-2343. PMID 18796620 DOI: 10.2337/Dc08-0277 |
0.323 |
|
| 2008 |
Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Stürmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis and Rheumatism. 59: 1097-104. PMID 18668605 DOI: 10.1002/Art.23911 |
0.371 |
|
| 2008 |
Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. American Heart Journal. 156: 31-6. PMID 18585494 DOI: 10.1016/J.Ahj.2008.03.021 |
0.343 |
|
| 2008 |
Everett BM, Glynn RJ, Danielson E, Ridker PM. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: A prespecified subgroup analysis of a community-based, randomized, open-label trial Clinical Therapeutics. 30: 661-672. PMID 18498915 DOI: 10.1016/J.Clinthera.2008.04.013 |
0.31 |
|
| 2008 |
Rao RS, Glickman ME, Glynn RJ. Stopping rules for surveys with multiple waves of nonrespondent follow-up. Statistics in Medicine. 27: 2196-213. PMID 17886234 DOI: 10.1002/Sim.3063 |
0.367 |
|
| 2008 |
Glynn RJ, Ridker PM, Zee RYL, Buring JE, Goldhaber SZ. Response to letter regarding article, "Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: Report from the women's health study" Circulation. 117: e313. DOI: 10.1161/Circulationaha.107.756437 |
0.304 |
|
| 2007 |
Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. The American Journal of Cardiology. 100: 1659-64. PMID 18036365 DOI: 10.1016/J.Amjcard.2007.09.072 |
0.306 |
|
| 2007 |
Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Annals of Internal Medicine. 147: 525-533. PMID 17938390 DOI: 10.7326/0003-4819-147-8-200710160-00004 |
0.356 |
|
| 2007 |
Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information Medical Care. 45: S158-S165. PMID 17909375 DOI: 10.1097/Mlr.0B013E318070C045 |
0.317 |
|
| 2007 |
Schneeweiss S, Patrick AR, Stürmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results Medical Care. 45: S131-S142. PMID 17909372 DOI: 10.1097/Mlr.0B013E318070C08E |
0.36 |
|
| 2007 |
Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. The American Journal of Cardiology. 100: 1061-7. PMID 17884362 DOI: 10.1016/J.Amjcard.2007.04.052 |
0.32 |
|
| 2006 |
Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 114: 2619-26. PMID 17116764 DOI: 10.1161/Circulationaha.106.660043 |
0.332 |
|
| 2006 |
Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis and Rheumatism. 54: 1378-89. PMID 16645966 DOI: 10.1002/Art.21887 |
0.33 |
|
| 2006 |
Glynn RJ, Schneeweiss S, Stürmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic & Clinical Pharmacology & Toxicology. 98: 253-9. PMID 16611199 DOI: 10.1111/J.1742-7843.2006.Pto_293.X |
0.302 |
|
| 2006 |
Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect American Journal of Epidemiology. 163: 262-270. PMID 16371515 DOI: 10.1093/Aje/Kwj047 |
0.304 |
|
| 2005 |
Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. American Journal of Epidemiology. 162: 975-82. PMID 16207808 DOI: 10.1093/Aje/Kwi309 |
0.335 |
|
| 2005 |
Kurth T, Hennekens CH, Stürmer T, Sesso HD, Glynn RJ, Buring JE, Gaziano JM. Analgesic use and risk of subsequent hypertension in apparently healthy men. Archives of Internal Medicine. 165: 1903-9. PMID 16157836 DOI: 10.1001/Archinte.165.16.1903 |
0.322 |
|
| 2005 |
Stürmer T, Schneeweiss S, Avorn J, Glynn RJ. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. American Journal of Epidemiology. 162: 279-89. PMID 15987725 DOI: 10.1093/Aje/Kwi192 |
0.315 |
|
| 2005 |
Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives Hypertension. 46: 273-279. PMID 15983239 DOI: 10.1161/01.Hyp.0000172753.96583.E1 |
0.323 |
|
| 2005 |
Bowman TS, Sesso HD, Glynn RJ, Gaziano JM. JNC 7 category and risk of cardiovascular death in men: are there differences by age? The American Journal of Geriatric Cardiology. 14: 126-31; quiz 132-3. PMID 15886538 DOI: 10.1111/J.1076-7460.2005.03809.X |
0.357 |
|
| 2005 |
Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial Circulation. 111: 2446-2453. PMID 15867184 DOI: 10.1161/01.Cir.0000165064.31505.3B |
0.312 |
|
| 2005 |
Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: Nonsteroidal antiinflammatory drugs and short-term mortality in the elderly American Journal of Epidemiology. 161: 891-898. PMID 15840622 DOI: 10.1093/Aje/Kwi106 |
0.345 |
|
| 2005 |
Wang PS, Schneeweiss S, Brookhart MA, Glynn RJ, Mogun H, Patrick AR, Avorn J. Suboptimal antidepressant use in the elderly. Journal of Clinical Psychopharmacology. 25: 118-26. PMID 15738742 DOI: 10.1097/01.Jcp.0000155819.67209.E5 |
0.318 |
|
| 2005 |
Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 53: 2883-92. PMID 15504969 DOI: 10.2337/Diabetes.53.11.2883 |
0.307 |
|
| 2005 |
Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 110: e7-12. PMID 15249517 DOI: 10.1161/01.Cir.0000135583.40730.21 |
0.328 |
|
| 2005 |
SCHNEEWEISS S, MACLURE M, DORMUTH C, GLYNN R, CANNING C, AVORN J. Clinical and economic consequences of formulary restrictions for three leading proton pump inhibitors Clinical Pharmacology & Therapeutics. 77: P1-P1. DOI: 10.1016/J.Clpt.2004.11.008 |
0.303 |
|
| 2004 |
Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ. Hemoglobin A1c level and future cardiovascular events among women. Archives of Internal Medicine. 164: 757-61. PMID 15078645 DOI: 10.1001/Archinte.164.7.757 |
0.326 |
|
| 2004 |
Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation. 109: 1623-9. PMID 15023883 DOI: 10.1161/01.Cir.0000124488.06377.77 |
0.341 |
|
| 2004 |
Rao RS, Glickman ME, Glynn RJ. Use of Covariates and Survey Wave to Adjust for Nonresponse Biometrical Journal. 46: 579-588. DOI: 10.1002/Bimj.200310049 |
0.394 |
|
| 2003 |
Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, Glynn RJ. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers Clinical Pharmacology and Therapeutics. 74: 388-400. PMID 14534526 DOI: 10.1016/S0009-9236(03)00227-3 |
0.302 |
|
| 2003 |
Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. The American Journal of Cardiology. 92: 682-6. PMID 12972106 DOI: 10.1016/S0002-9149(03)00822-1 |
0.329 |
|
| 2003 |
Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, Gaziano JM. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs Circulation. 108: 1191-1195. PMID 12939216 DOI: 10.1161/01.Cir.0000087593.07533.9B |
0.346 |
|
| 2003 |
Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, ... ... Glynn RJ, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. The New England Journal of Medicine. 348: 1425-34. PMID 12601075 DOI: 10.1056/Nejmoa035029 |
0.316 |
|
| 2003 |
Sesso HD, Gaziano JM, VanDenburgh M, Hennekens CH, Glynn RJ, Buring JE. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study. Controlled Clinical Trials. 23: 686-702. PMID 12505246 DOI: 10.1016/S0197-2456(02)00235-0 |
0.346 |
|
| 2003 |
Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. Journal of the American Society of Nephrology : Jasn. 13: 2353-62. PMID 12191980 DOI: 10.1097/01.Asn.0000025785.41314.76 |
0.31 |
|
| 2002 |
Avorn J, Benner J, Ford I, Ganz DA, Gaw A, Glynn RJ, Jackson J, Lagaay AM, Schneeweiss S, Walley T, Wang PS. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Controlled Clinical Trials. 23: 757-73. PMID 12505250 DOI: 10.1016/S0197-2456(02)00228-3 |
0.365 |
|
| 2002 |
Wang PS, Glynn RJ, Ganz DA, Schneeweiss S, Levin R, Avorn J. Clozapine use and risk of diabetes mellitus. Journal of Clinical Psychopharmacology. 22: 236-43. PMID 12006892 DOI: 10.1097/00004714-200206000-00002 |
0.328 |
|
| 2002 |
Solomon DH, Ganz DA, Avorn J, Glynn RJ, Knight EL, Gibson CM, Stone PH. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. Journal of Clinical Epidemiology. 55: 121-8. PMID 11809349 DOI: 10.1016/S0895-4356(01)00427-9 |
0.321 |
|
| 2002 |
Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 39: 105-10. PMID 11799087 DOI: 10.1161/Hy1201.097199 |
0.326 |
|
| 2001 |
Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 38: 1178-84. PMID 11728948 DOI: 10.1053/Ajkd.2001.29207 |
0.306 |
|
| 2001 |
Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. American Journal of Epidemiology. 154: 854-64. PMID 11682368 DOI: 10.1093/Aje/154.9.854 |
0.301 |
|
| 2001 |
Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology (Cambridge, Mass.). 12: 682-9. PMID 11679797 DOI: 10.1097/00001648-200111000-00017 |
0.308 |
|
| 2001 |
Solomon DH, Stone PH, Glynn RJ, Ganz DA, Gibson CM, Tracy R, Avorn J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Journal of the American College of Cardiology. 38: 969-976. PMID 11583866 DOI: 10.1016/S0735-1097(01)01503-0 |
0.328 |
|
| 2001 |
Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 104: 393-8. PMID 11468199 DOI: 10.1161/Hc2901.093115 |
0.306 |
|
| 2001 |
Christen WG, Ajani UA, Schaumberg DA, Glynn RJ, Manson JE, Hennekens CH. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Archives of Ophthalmology (Chicago, Ill. : 1960). 119: 405-12. PMID 11231774 DOI: 10.1001/Archopht.119.3.405 |
0.335 |
|
| 2001 |
Christen WG, Ajani U, Schaumberg D, Glynn R, Manson J, Hennekens C, Fine IH. Aspirin use and risk of cataract in posttrial follow-up Evidence-Based Eye Care. 2: 228-229. DOI: 10.1097/00132578-200110000-00021 |
0.302 |
|
| 2001 |
Benner J, Federman A, Smitten A, Duty S, Glynn R, Avorn J. PCV24: BEYOND THE FIRST YEAR: PATTERNS AND PREDICTORS OF LONG-TERM STATIN UTILIZATION Value in Health. 4: 104. DOI: 10.1046/J.1524-4733.2001.40202-98.X |
0.322 |
|
| 2000 |
Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism Journal of General Internal Medicine. 15: 776-781. PMID 11119169 DOI: 10.1046/J.1525-1497.2000.91022.X |
0.321 |
|
| 2000 |
Knight EL, Glynn RJ, Levin R, Ganz DA, Avorn J. Failure of evidence-based medicine in the treatment of hypertension in older patients Journal of General Internal Medicine. 15: 702-709. PMID 11089713 DOI: 10.1046/J.1525-1497.2000.91020.X |
0.314 |
|
| 2000 |
Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Archives of Internal Medicine. 160: 422-34. PMID 10695683 DOI: 10.1001/Archinte.160.4.422 |
0.311 |
|
| 2000 |
Stürmer T, Glynn RJ, Kliebsch U, Brenner H. Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. Journal of Clinical Epidemiology. 53: 57-64. PMID 10693904 DOI: 10.1016/S0895-4356(99)00137-7 |
0.311 |
|
| 2000 |
Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Manson JE, Buring JE, Hennekens CH. Baseline self-reported cataract and subsequent mortality in Physicians' Health Study I Ophthalmic Epidemiology. 7: 115-125. DOI: 10.1076/0928-6586(200006)721-Zft115 |
0.333 |
|
| 1999 |
Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. American Journal of Epidemiology. 149: 541-9. PMID 10084243 DOI: 10.1093/Oxfordjournals.Aje.A009850 |
0.303 |
|
| 1999 |
Christen WG, Ajani UA, Glynn RJ, Manson JE, Schaumberg DA, Chew EC, Buring JE, Hennekens CH. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. American Journal of Epidemiology. 149: 476-84. PMID 10067908 DOI: 10.1093/Oxfordjournals.Aje.A009836 |
0.342 |
|
| 1999 |
Christen WG, Manson JE, Glynn RJ, Ajani UA, Schaumberg DA, Sperduto RD, Buring JE, Hennekens CH. Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians. Ophthalmic Epidemiology. 5: 133-42. PMID 9805346 DOI: 10.1076/Opep.5.3.133.8368 |
0.309 |
|
| 1998 |
Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J. Patient Noncompliance in the Managed Care Setting: The Case of Medical Therapy for Glaucoma Medical Care. 36: 357-369. PMID 9520960 DOI: 10.1097/00005650-199803000-00012 |
0.304 |
|
| 1997 |
Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Thiazide diuretics and the initiation of anti-gout therapy. Journal of Clinical Epidemiology. 50: 953-9. PMID 9291881 DOI: 10.1016/S0895-4356(97)00101-7 |
0.331 |
|
| 1997 |
Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. American Journal of Hypertension. 10: 697-704. PMID 9234822 DOI: 10.1016/S0895-7061(97)00056-3 |
0.336 |
|
| 1995 |
Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study. Archives of Internal Medicine. 154: 2649-57. PMID 7993148 DOI: 10.1001/Archinte.1994.00420230032005 |
0.314 |
|
| 1995 |
Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (Dallas, Tex. : 1979). 25: 1045-51. PMID 7737714 DOI: 10.1161/01.Hyp.25.5.1045 |
0.329 |
|
| 1995 |
Glynn RJ, Brock DB, Harris T, Havlik RJ, Chrischilles EA, Ostfeld AM, Taylor JO, Hennekens CH. Use of Antihypertensive Drugs and Trends in Blood Pressure in the Elderly Archives of Internal Medicine. 155: 1855-1860. PMID 7677551 DOI: 10.1001/Archinte.1995.00430170043005 |
0.321 |
|
| 1995 |
O’Donnell CJ, Ridker PM, Berger K, LaMotte F, Glynn RJ, Manson JE, Hennekens CH. 901-79 Borderline Isolated Systolic Hypertension and Subsequent Risk of Cardiovascular Disease Journal of the American College of Cardiology. 25: 24A. DOI: 10.1016/0735-1097(95)91556-D |
0.339 |
|
| 1994 |
Manson JE, Christen WG, Seddon JM, Glynn RJ, Hennekens CH. A Prospective Study of Alcohol Consumption and Risk of Cataract American Journal of Preventive Medicine. 10: 156-161. DOI: 10.1016/S0749-3797(18)30612-3 |
0.311 |
|
| 1993 |
Avorn J, Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Everitt DE, Gilden D, Choodnovskiy I. Adverse Pulmonary Effects of Topical ?? Blockers Used in the Treatment of Glaucoma Journal of Glaucoma. 2: 158???165. DOI: 10.1097/00061198-199300230-00003 |
0.34 |
|
| 1993 |
Christen W, Manson J, Seddon J, Glynn R, Buring J, Rosner B, Hennekens C. A prospective study of cigarette smoking and risk of cataract in men Journal of Safety Research. 24: 129-130. DOI: 10.1001/Jama.1992.03490080063025 |
0.319 |
|
| 1992 |
de Labry LO, Glynn RJ, Levenson MR, Hermos JA, LoCastro JS, Vokonas PS. Alcohol consumption and mortality in an American male population: recovering the U-shaped curve--findings from the normative Aging Study. Journal of Studies On Alcohol. 53: 25-32. PMID 1556854 DOI: 10.15288/Jsa.1992.53.25 |
0.303 |
|
| 1991 |
Glynn RJ, Seddon JM, Krug JH, Sahagian CR, Chiavelli ME, Campion EW. Falls in elderly patients with glaucoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 109: 205-10. PMID 1993029 DOI: 10.1001/Archopht.1991.01080020051041 |
0.323 |
|
| 1991 |
Glynn RJ, Schein OD, Seddon JM, Poggio EC, Goodfellow JR, Scardino VA, Shannon MJ, Kenyon KR. The incidence of ulcerative keratitis among aphakic contact lens wearers in New England. Archives of Ophthalmology (Chicago, Ill. : 1960). 109: 104-7. PMID 1987926 DOI: 10.1001/Archopht.1991.01080010106041 |
0.311 |
|
| 1990 |
Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 96: 1716-21. PMID 2622616 DOI: 10.1016/S0161-6420(89)32659-5 |
0.302 |
|
| 1990 |
Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Archives of Ophthalmology (Chicago, Ill. : 1960). 108: 1274-80. PMID 2400347 DOI: 10.1001/Archopht.1990.01070110090031 |
0.319 |
|
| 1990 |
de Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. Journal of Clinical Epidemiology. 43: 153-7. PMID 2303845 DOI: 10.1016/0895-4356(90)90178-R |
0.327 |
|
| 1990 |
Austin KL, Palmer JR, Seddon JM, Glynn RJ, Rosenberg L, Gragoudas ES, Kaufman DW, Shapiro S. Case-control study of idiopathic retinal detachment. International Journal of Epidemiology. 19: 1045-50. PMID 2083988 DOI: 10.1093/Ije/19.4.1045 |
0.323 |
|
| 1982 |
Glynn RJ, Rosner B, Silbert JE. Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men. Circulation. 66: 724-31. PMID 7116589 DOI: 10.1161/01.Cir.66.4.724 |
0.317 |
|
| Show low-probability matches. |